Kristin Abate Karyopharm Therapeutics Inc. (KPTI) insider trading activity

KPTI Quotes by TradingView

Kristin Abate is Chief Accounting Officer of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 10,046 shares of KPTI, which is worth approximately $47,718. The most recent transaction as insider was on Oct 01, 2025, when has been sold 362 shares (Common Stock) at a price of $6.3 per share, resulting in proceeds of $2,280. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10K
3.43% 3M change
n/a 12M change
Total Value Held $47,718

Kristin Abate Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 01 2025
SELL
Open market or private sale
$2,280 $6.3 p/Share
362 Reduced 3.48%
10,046 Common Stock
Sep 15 2025
SELL
Open market or private sale
$147 $6.43 p/Share
23 Reduced 0.22%
10,408 Common Stock
Sep 12 2025
BUY
Grant, award, or other acquisition
-
46 Added 0.44%
10,431 Common Stock
Sep 03 2025
SELL
Open market or private sale
$81 $6.78 p/Share
12 Reduced 0.13%
9,463 Common Stock
Jul 22 2025
SELL
Open market or private sale
$952 $4.0 p/Share
238 Reduced 2.45%
9,475 Common Stock
Mar 04 2025
SELL
Open market or private sale
$3,591 $6.29 p/Share
571 Reduced 5.55%
9,713 Common Stock
Feb 28 2025
BUY
Grant, award, or other acquisition
-
933 Added 8.32%
10,284 Common Stock
KA

Kristin Abate

Chief Accounting Officer
Newton, MA

Track Institutional and Insider Activities on KPTI

Follow Karyopharm Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPTI shares.

Notify only if

Insider Trading

Get notified when an Karyopharm Therapeutics Inc. insider buys or sells KPTI shares.

Notify only if

News

Receive news related to Karyopharm Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KPTI